Intensity of Androgen and Epidermal Growth Factor Receptor Immunoreactivity in Samples of Radical Prostatectomy as Prognostic Indicator: Correlation With Clinical Data of Long-Term Observations-Reference-Cited by-同舟云学术

Intensity of Androgen and Epidermal Growth Factor Receptor Immunoreactivity in Samples of Radical Prostatectomy as Prognostic Indicator: Correlation With Clinical Data of Long-Term Observations

Published:2006-08 Issue:2 Volume:176 Page:532-537
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Schäfer Wolfgang¹,Funke Peter-Jörg¹,Kunde Dieter²,Rausch Ulrich³,Wennemuth Gunther³,Stützer Hartmut⁴

Affiliation:

1. Department of Urology, Jung-Stilling-Hospital, Siegen

2. Department of Pathology, Jung-Stilling-Hospital, Siegen

3. Department of Anatomy and Cell Biology, University of Marburg, Marburg

4. Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Köln, Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer;Zincke;J Urol,1994

2. Regulation of prostatic growth and function by peptide growth factors;Culig;Prostate,1996

3. Androgenic regulation of epidermal growth factor in the mouse ventral prostate;Hiramatsu;Biochem Int,1988

4. Hormone-induced morphogenesis and growth;Cunha;Recent Progr Horm Res,1983

5. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer;Henshall;Cancer Res,2001

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression;The Journal of Pathology: Clinical Research;2023-04-18

2. Neoplasms of the Prostate;Urologic Surgical Pathology;2020

3. Nonneoplastic Diseases of the Prostate;Urologic Surgical Pathology;2020

4. The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review;Journal of Cancer Research and Clinical Oncology;2012-11-28

5. PTENgenomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity;BMC Cancer;2012-11-22